Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6648138 | 0.99 | FNTA (0.52) | FNTAFNTB | |
| Lithium Ion SCHEMBL7871084 | 0.92 | — | — | |
| SCHEMBL7869153 | 0.89 | — | — | |
| SCHEMBL7869150 | 0.89 | — | — | |
| Lithium Ion SCHEMBL7869147 | 0.83 | — | — | |
| Lithium Ion SCHEMBL7869136 | 0.82 | — | — | |
| Lithium Ion SCHEMBL7862372 | 0.82 | — | — | |
| SCHEMBL6645514 | 0.82 | — | — | |
| SCHEMBL628620 | 0.81 | — | — | |
| SCHEMBL628619 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6310095-B1 | INHIBITING OR TREATING CANCER, TREATING INTIMAL HYPERPLASIA ASSOCIATED WITH RESTENOSIS AND ATHEROSCLEROSIS, INHIBITING POST-TRANSLATIONAL MODIFICATION OF ONCOGENIC RAS PROTEIN BY PROTEIN FARNESYLTRANSFERASE AND/OR GERANYLGERANYLTRANSFERASE | UNIVERSITY OF PITTSBURGH | 2001-10-30 | — | — | US | disclosed |